Iris Vered

2.0k total citations
56 papers, 1.6k citations indexed

About

Iris Vered is a scholar working on Orthopedics and Sports Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Iris Vered has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Orthopedics and Sports Medicine, 17 papers in Oncology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Iris Vered's work include Bone health and osteoporosis research (20 papers), Bone health and treatments (12 papers) and Vitamin D Research Studies (7 papers). Iris Vered is often cited by papers focused on Bone health and osteoporosis research (20 papers), Bone health and treatments (12 papers) and Vitamin D Research Studies (7 papers). Iris Vered collaborates with scholars based in Israel, United States and Czechia. Iris Vered's co-authors include Louis V. Avioli, William A. Peck, Robert E. Pacifici, C. Meghan McMurtry, Ruth McCracken, Leonard Rifas, Perla Werner, Haim Mayan, Meir Mouallem and Rachel Pauzner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and The American Journal of Medicine.

In The Last Decade

Iris Vered

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Vered Israel 21 528 499 372 217 204 56 1.6k
Juraj Payer Slovakia 20 482 0.9× 293 0.6× 250 0.7× 315 1.5× 351 1.7× 132 1.9k
R. Rizzoli Switzerland 21 833 1.6× 348 0.7× 341 0.9× 432 2.0× 161 0.8× 47 1.5k
Thomas V. Paul India 23 351 0.7× 217 0.4× 182 0.5× 423 1.9× 176 0.9× 166 1.6k
G. Gamble New Zealand 25 287 0.5× 372 0.7× 318 0.9× 458 2.1× 163 0.8× 53 2.1k
S. Murphy United Kingdom 21 556 1.1× 153 0.3× 161 0.4× 190 0.9× 303 1.5× 41 1.4k
A.A. Rouzi Saudi Arabia 22 527 1.0× 354 0.7× 280 0.8× 417 1.9× 224 1.1× 86 1.8k
Harold N. Rosen United States 25 1.4k 2.6× 672 1.3× 789 2.1× 393 1.8× 344 1.7× 68 2.6k
M. Sosa Henríquez Spain 24 796 1.5× 231 0.5× 291 0.8× 527 2.4× 559 2.7× 150 1.7k
M C Evans New Zealand 21 1.3k 2.4× 311 0.6× 489 1.3× 358 1.6× 257 1.3× 41 2.1k
C Cooper United States 5 1.7k 3.1× 450 0.9× 572 1.5× 705 3.2× 321 1.6× 8 2.4k

Countries citing papers authored by Iris Vered

Since Specialization
Citations

This map shows the geographic impact of Iris Vered's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Vered with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Vered more than expected).

Fields of papers citing papers by Iris Vered

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Vered. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Vered. The network helps show where Iris Vered may publish in the future.

Co-authorship network of co-authors of Iris Vered

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Vered. A scholar is included among the top collaborators of Iris Vered based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Vered. Iris Vered is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zacay, Galia, Noam Tau, Yael Levy‐Shraga, et al.. (2023). Trabecular Bone Score Change Is Not Predicted by Bone Turnover: Short-term Sequential Follow-up.. PubMed. 25(6). 438–442. 1 indexed citations
2.
Tripto‐Shkolnik, Liana, et al.. (2021). Bone Mineral Density of the 1/3 Radius Refines Osteoporosis Diagnosis, Correlates With Prevalent Fractures, and Enhances Fracture Risk Estimates. Endocrine Practice. 27(5). 408–412. 6 indexed citations
3.
Gendelman, Omer, et al.. (2021). Bisphosphonates Related Ocular Side Effects: A Case Series and Review of Literature. Ocular Immunology and Inflammation. 30(7-8). 1995–1999. 5 indexed citations
4.
Levy‐Shraga, Yael, et al.. (2018). Low trabecular bone score in adolescent female inpatients with anorexia nervosa. Clinical Nutrition. 38(3). 1166–1170. 19 indexed citations
5.
Tripto‐Shkolnik, Liana, Vanessa Rouach, Yonit Marcus, et al.. (2018). Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates. Calcified Tissue International. 103(1). 44–49. 40 indexed citations
6.
Dresner–Pollak, Rivka, et al.. (2012). Illness perceptions among osteoporotic men and women: correlates and gender differences. Journal of Men s Health. 9(3). 168–175. 10 indexed citations
7.
Werner, Perla, et al.. (2005). Management of Osteoporosis. Journal of Nutrition for the Elderly. 25(1). 83–97. 4 indexed citations
8.
Werner, Perla, David Olchovsky, & Iris Vered. (2005). Osteoporosis health-related behavior among healthy peri-menopausal and post-menopausal Israeli Jewish and Arab women. Aging Clinical and Experimental Research. 17(2). 100–107. 9 indexed citations
9.
Werner, Perla, et al.. (2003). Osteoporosis health-related behaviors in secular and orthodox Israeli Jewish women. Maturitas. 46(4). 283–294. 21 indexed citations
10.
Werner, Perla, et al.. (2003). First-degree relatives of persons suffering from osteoporosis: beliefs, knowledge, and health-related behavior. Osteoporosis International. 14(4). 306–311. 14 indexed citations
11.
Werner, Perla & Iris Vered. (2002). Women's knowledge of new regulations about publicly funded medications for osteoporosis. Health Policy. 60(3). 275–284. 1 indexed citations
12.
Werner, Perla & Iris Vered. (2000). Management of osteoporosis: a survey of Israeli physicians' knowledge and attitudes.. PubMed. 2(5). 361–4. 18 indexed citations
13.
Givon, Uri, Eitan Friedman, Anat Reiner‐Benaim, et al.. (2000). Stress Fractures in the Israeli Defense Forces From 1995 to 1996. Clinical Orthopaedics and Related Research. 373(373). 227–232. 45 indexed citations
14.
Cohen, Ohad, Theodor Rais, E. Lepkifker, & Iris Vered. (1998). Lithium Carbonate Therapy is not a Risk Factor for Osteoporosis. Hormone and Metabolic Research. 30(9). 594–597. 33 indexed citations
15.
Vered, Iris. (1997). Cross Genotype Sex Hormone Treatment in Two Cases of Hypogonadal Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 82(2). 576–578. 2 indexed citations
16.
Vered, Iris, Igor Kaiserman, Ben‐Ami Sela, & Joseph Sack. (1997). Cross Genotype Sex Hormone Treatment in Two Cases of Hypogonadal Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 82(2). 576–578. 8 indexed citations
17.
Rupich, Reta C., Roberto Pacifici, Michael G. Griffin, et al.. (1990). LATERAL DUAL ENERGY RADIOGRAPHY: A NEW METHOD FOR MEASURING VERTEBRAL BONE DENSITY: A PRELIMINARY STUDY. The Journal of Clinical Endocrinology & Metabolism. 70(6). 1768–1770. 35 indexed citations
18.
Pacifici, Roberto, Cynthia T. McMurtry, Iris Vered, Reta C. Rupich, & Louis V. Avioli. (1988). Coherence Therapy Does Not Prevent Axial Bone Loss in Osteoporotic Women: A Preliminary Comparative Study. The Journal of Clinical Endocrinology & Metabolism. 66(4). 747–753. 65 indexed citations
19.
Vered, Iris, et al.. (1985). Rhinocerebral phycomycosis; combined approach therapy: case report. The Journal of Laryngology & Otology. 99(12). 1279–1280. 4 indexed citations
20.
Vered, Iris, et al.. (1976). [Foreign bodies of the upper respiratory tract in children].. PubMed. 91(9). 280–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juraj Payer Breakdown of academic impact, for papers by R. Rizzoli Breakdown of academic impact, for papers by Thomas V. Paul Breakdown of academic impact, for papers by G. Gamble Breakdown of academic impact, for papers by S. Murphy Breakdown of academic impact, for papers by A.A. Rouzi Breakdown of academic impact, for papers by Harold N. Rosen Breakdown of academic impact, for papers by M. Sosa Henríquez Breakdown of academic impact, for papers by M C Evans Breakdown of academic impact, for papers by C Cooper
Rankless by CCL
2026